All-oral 12-week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3: ALLY-3 Phase 3 Study

被引：0

作者：

Nelson, David R. ^{[1
]}

Cooper, James N. ^{[2
]}

Lalezari, Jacob P. ^{[3
]}

Lawitz, Eric ^{[4
]}

Pockros, Paul J. ^{[5
]}

Gitlin, Norman ^{[6
]}

Freilich, Bradley ^{[7
]}

Younes, Ziad ^{[8
]}

Harlan, William ^{[9
]}

Ghalib, Reem H. ^{[10
]}

Oguchi, Godson I. ^{[11
]}

Thuluvath, Paul J. ^{[12
]}

Ortiz-Lasanta, Grisell ^{[13
]}

Rabinovitz, Mordechai ^{[14
]}

Bernstein, David ^{[15
]}

Bennett, Michael ^{[16
]}

Hawkins, Trevor ^{[17
]}

Ravendhran, Natarajan ^{[18
]}

Sheikh, Aasim M. ^{[19
]}

Varunok, Peter ^{[20
]}

Kowdley, Kris V. ^{[21
]}

Hennicken, Delphine ^{[22
]}

McPhee, Fiona ^{[22
]}

Rana, Khurram ^{[22
]}

Hughes, Eric A. ^{[22
]}

机构：

[1] Univ Florida, Gainesville, FL USA

[2] Inova Fairfax Hosp, Falls Church, VA USA

[3] Quest Clin Res, San Francisco, CA USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA

[5] Scripps Clin, La Jolla, CA 92037 USA

[6] Atlanta Gastroenterol Associates, Atlanta, GA USA

[7] Kansas City Res Inst, Kansas City, MO USA

[8] Gastro One, Germantown, TN USA

[9] Asheville Gastroenterol Associates, Asheville, NC USA

[10] Texas Clin Res Inst, Arlington, TX USA

[11] Midland Florida Clin Res Ctr, Deland, FL USA

[12] Mercy Med Ctr, Baltimore, MD USA

[13] Fdn Invest Diego, Santurce, PR USA

[14] Univ Pittsburgh, Pittsburgh, PA USA

[15] Hofstra North Shore Long Isl Jewish Sch Med, Manhasset, NY USA

[16] Med Associates Res Grp, San Diego, CA USA

[17] Southwest CARE Ctr, Santa Fe, NM USA

[18] Digest Dis Associates, Baltimore, MD USA

[19] Gastrointestinal Specialists Georgia, Marietta, GA USA

[20] Premier Med Grp Husdon Valley, Poughkeepsie, NY USA

[21] Swedish Med Ctr, Seattle, WA USA

[22] Bristol Myers Squibb Res & Dev, Princeton, NJ USA

来源：

HEPATOLOGY | 2014年 / 60卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-3

引用

页码：1268A / 1269A

页数：2

共 50 条

[1] ALL-ORAL 12-WEEK COMBINATION TREATMENT WITH DACLATASVIR (DCV) AND SOFOSBUVIR (SOF) IN TREATMENT-EXPERIENCED PATIENTS INFECTED WITH HCV GENOTYPE (GT) 3: A SUBANALYSIS OF THE ALLY-3 PHASE 3 STUDY
Nelson, D.
Bernstein, D.
Freilich, B.
Lawitz, E.
Hawkins, T.
Pockros, P.
Thuluvath, P.
Younes, Z.
Bennett, M.
Ghalib, R.
Ruane, P. J.
Tong, M.
Bhore, R.
Yin, P. D.
Noviello, S.
Rana, K.
JOURNAL OF HEPATOLOGY, 2015, 62 : S624 - S624
[2] All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study
Nelson, David
Bernstein, David
Freilich, Bradley
Lawitz, Eric
Hawkins, Trevor
Pockros, Paul J.
Thuluvath, Paul J.
Younes, Ziad H.
Bennett, Michael
Ghalib, Reem
Ruane, Peter J.
Tong, Myron J.
Bhore, Rafia
Yin, Philip D.
Noviello, Stephanie
Rana, Khurram
GASTROENTEROLOGY, 2015, 148 (04) : S1003 - S1003
[3] All-oral 12-week treatment with daclatasvir and sofosbuvir in treatment-experienced patients infected with HCV genotype 3: a subanalysis of the ALLY-3 phase 3 study
Nelson, D.
Bernstein, D.
Freilich, B.
Lawitz, E.
Hawkins, T.
Pockros, P.
Thuluvath, P.
Younes, Z.
Bennett, M.
Ghalib, R.
Peter, R.
Tong, M.
Bhore, R.
Yin, P.
Noviello, S.
Rana, K.
JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 30 - 30
[4] All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
Nelson, David R.
Cooper, James N.
Lalezari, Jacob P.
Lawitz, Eric
Pockros, Paul J.
Gitlin, Norman
Freilich, Bradley F.
Younes, Ziad H.
Harlan, William
Ghalib, Reetn
Oguchi, Godson
Thuluvath, Paul J.
Ortiz-Lasanta, Grisell
Rabinovitz, Mordechai.
Berastein, David
Bennett, Michael
Hawkins, Trevor
Ravendhran, Natarajan
Sheikh, Aasim M.
Varunok, Peter
Kowdley, Kris V.
Hennicken, Delphine
McPhee, Fiona
Rana, Ithurram
Hughes, Eric A.
HEPATOLOGY, 2015, 61 (04) : 1127 - 1135
[5] All-Oral Treatment With Daclatasvir (DCV) Plus Sofosbuvir (SOF) Plus Ribavirin (RBV) for 12 or 16 Weeks in HCV Genotype (GT) 3-Infected Patients With Advanced Fibrosis or Cirrhosis: The ALLY-3+Phase 3 Study
Leroy, Vincent
Angus, Peter W.
Bronowicki, Jean-Pierre
Dore, Gregory
Hezode, Christophe
Pianko, Stephen
Pol, Stanislas
Stuart, Katherine A.
Tse, Edmund
McPhee, Fiona
Bhore, Rafia
Exposito, Maria Jesus Jimenez
Thompson, Alex J.
HEPATOLOGY, 2015, 62 (06) : 1380A - 1381A
[6] ALL-ORAL TREATMENT WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN IN HCV GENOTYPE 3-INFECTED PATIENTS WITH ADVANCED FIBROSIS OR CIRRHOSIS: AN ANALYSIS OF ALLY-3 AND ALLY-3+
Kowdley, K.
Angus, P.
Bernstein, D.
Bronowicki, J. -P.
Leroy, V.
Pockros, P.
Bhore, R.
Rana, K.
Jimenez-Exposito, M. J.
JOURNAL OF HEPATOLOGY, 2016, 64 : S789 - S790
[7] All-Oral Treatment With Daclatasvir Plus Sofosbuvir ± Ribavirin in HCV Genotype 3-Infected Patients With Advanced Fibrosis or Cirrhosis: An Analysis of ALLY-3 and ALLY-3+
Kowdley, Kris V.
Angus, Peter
Bernstein, David
Bronowicki, Jean-Pierre
Leroy, Vincent
Pockros, Paul J.
Bhore, Rafia
Rana, Khurram
Jimenez-Exposito, Maria Jesus
GASTROENTEROLOGY, 2016, 150 (04) : S1094 - S1094
[8] ON-TREATMENT HCVRNA AS A PREDICTOR OF SUSTAINED VIROLOGIC RESPONSE IN HCV GENOTYPE 3 INFECTED PATIENTS TREATED WITH DACLATASVIR AND SOFOSBUVIR: ANALYSIS OF PHASE 3 ALLY-3 STUDY
Kowdley, K.
Nelson, D.
Lalezari, J.
Box, T.
Gitlin, N.
Poleynard, G.
Rabinovitz, M.
Ravendhran, N.
Sheikh, A.
Siddique, A.
Bhore, R.
Yin, P. D.
Noviello, S.
Rana, K.
JOURNAL OF HEPATOLOGY, 2015, 62 : S648 - S648
[9] On-Treatment HCV RNA As a Predictor of Sustained Virologic Response in HCV Genotype 3-Infected Patients Treated With Daclatasvir and Sofosbuvir: Analysis of Phase 3 Ally-3 Study
Kowdley, Kris
Nelson, David
Lalezari, Jacob
Box, Terry
Gitlin, Norman
Poleynard, Gary D.
Rabinovitz, Mordechai
Ravendhran, Natarajan
Sheikh, Aasim M.
Siddique, Asma
Bhore, Rafia
Yin, Philip D.
Noviello, Stephanie
Rana, Khurram
GASTROENTEROLOGY, 2015, 148 (04) : S1084 - S1084
[10] ALL-ORAL SOFOSBUVIR-BASED 12-WEEK REGIMENS FOR THE TREATMENT OF CHRONIC HCV INFECTION: THE ELECTRON STUDY
Gane, E. J.
Stedman, C. A.
Hyland, R. H.
Pang, P. S.
Ding, X.
Symonds, W. T.
McHutchison, J. G.
JOURNAL OF HEPATOLOGY, 2013, 58 : S6 - S7

← 1 2 3 4 5 →